Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Pediatric Hematology
How long do you continue to follow children with now resolved autoimmune hemolytic anemia in hematology clinic to monitor for recurrence or secondary conditions?
Related Questions
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?
How would you manage aplastic anemia refractory to multiple agents?
Does continuous platelet transfusion reduce platelet refractoriness in ECMO?
In what clinical scenario would you consider liver transplant evaluation for a patient with sickle cell hepatopathy?
In an adult patient with asymptomatic, isolated neutropenia in whom you suspect a Duffy null phenotype, at what ANC or in what situations would you do a bone marrow to look for other etiologies of neutropenia?
What are your top takeaways from ISTH 2025?
When would you consider genetic testing for G6PD deficiency diagnosis?
What diagnostic workup is recommended when immune thrombocytopenia is present in multiple family members?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
